tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LEXX Stock Latest News

Lexaria Bioscience Enhances Capital with Warrant Exercise
Company AnnouncementsLexaria Bioscience Enhances Capital with Warrant Exercise
2d ago
LEXX
Lexaria Advances with New GLP-1 Drug Study
PremiumCompany Announcements
Lexaria Advances with New GLP-1 Drug Study
16d ago
LEXX
Lexaria Bioscience receives ethics review board approval for GLP-1 study
PremiumThe Fly
Lexaria Bioscience receives ethics review board approval for GLP-1 study
16d ago
LEXX
Lexaria Secures New Patents, Bolsters Pharma Tech
PremiumCompany Announcements
Lexaria Secures New Patents, Bolsters Pharma Tech
1M ago
LEXX
Lexaria Bioscience Showcases Drug Delivery Breakthrough
PremiumCompany Announcements
Lexaria Bioscience Showcases Drug Delivery Breakthrough
1M ago
LEXX
Lexaria Bioscience Welcomes New CFO
PremiumCompany AnnouncementsLexaria Bioscience Welcomes New CFO
2M ago
LEXX
Lexaria Bioscience appoints Nelson Cabatuan as CFO
PremiumThe Fly
Lexaria Bioscience appoints Nelson Cabatuan as CFO
2M ago
LEXX
Lexaria Bioscience files to sell 1.61M shares of common stock for holders
PremiumThe Fly
Lexaria Bioscience files to sell 1.61M shares of common stock for holders
2M ago
LEXX
Lexaria Bioscience Advances Oral Diabetes Treatment
PremiumCompany Announcements
Lexaria Bioscience Advances Oral Diabetes Treatment
2M ago
LEXX
Lexaria Bioscience hires CRO for GLP-1 human pilot study
PremiumThe Fly
Lexaria Bioscience hires CRO for GLP-1 human pilot study
2M ago
LEXX
Lexaria Tests New Diabetes and Weight Loss Formulations
PremiumCompany Announcements
Lexaria Tests New Diabetes and Weight Loss Formulations
2M ago
LEXX
Lexaria Bioscience price target raised to $12 from $3 at Maxim
PremiumThe Fly
Lexaria Bioscience price target raised to $12 from $3 at Maxim
2M ago
LEXX
Lexaria Advances Drug Delivery with Promising Study
PremiumCompany AnnouncementsLexaria Advances Drug Delivery with Promising Study
2M ago
LEXX
Lexaria Bioscience says DehydraTECH-CBD study resulted in weight loss in rodents
PremiumThe Fly
Lexaria Bioscience says DehydraTECH-CBD study resulted in weight loss in rodents
2M ago
LEXX
Lexaria Bioscience announces FDA clearance of Phase 1b hypertension trial
PremiumThe Fly
Lexaria Bioscience announces FDA clearance of Phase 1b hypertension trial
2M ago
LEXX
Lexaria Bioscience prices $3.6M registered direct offering at $2.31 per share
PremiumThe Fly
Lexaria Bioscience prices $3.6M registered direct offering at $2.31 per share
3M ago
LEXX
Lexaria Bioscience submits IND application to FDA for DehydraTECH-CBD trial
PremiumThe Fly
Lexaria Bioscience submits IND application to FDA for DehydraTECH-CBD trial
3M ago
LEXX
Lexaria Bioscience says ‘never been more confident’ in IP portfolio
PremiumThe Fly
Lexaria Bioscience says ‘never been more confident’ in IP portfolio
3M ago
LEXX
Lexaria Bioscience unveils planned 2024 GLP-1 study program
PremiumThe Fly
Lexaria Bioscience unveils planned 2024 GLP-1 study program
4M ago
LEXX
Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
PremiumPress ReleasesLexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream
4M ago
LEXX
Lexaria Bioscience announces availability of broadcast on GLP-1
PremiumThe Fly
Lexaria Bioscience announces availability of broadcast on GLP-1
4M ago
LEXX
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
PremiumPress Releases
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
4M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >